|Brawn Pharmaceuticals ltd an existing profit making company was incorporated as a private limited company in the name and style of Brawn Pharmaceuticals Pvt. Ltd. on 7th November, 1985 and was converted into a public limited company on 1st December, 1993. The company started its activities by selling pharmaceutical formulations manufactured by other companies on loan licence basis.
In December, 1987 the company setup its own manufacturing facilities for manufacture of pharamaceutical formulations at W-11, Okhla Industrial Area, Phase-II, New Delhi. The plant became operational from July 1988. Since then there has been steady growth in its operations relating to formulations in tablets, capsules, and oral syrups and trading in other related items. Since the year 1989-90 the company has registered an average growth of 53% in its turnover. The company has also obtained marketing rights from few foreign companies for selling thier medical products in the domestic market.
The products manufactures by the company are in the categories of Analgesics, Antibiotics, Anti Tuberculosis, Antiinflammatory, Antipyretic, Anti Malarial, B Comples and Amino Acids, Cardiovascular drugs, Antiphyscotropic drugs, Tranquilizers, Antacids, Haematinics and proteins with an installed capacity of 2000 lakhs tablets, 150 lakhs capsules and 2.00 lakhs liters of liquid syrup. The main registered branded products of the company include Bruprim, Bruhist, Brutone, Brugesic.
The Company is also marketing various products viz portaneb, freewaylite, CR-50, Patented side stream nebulizers, of multinational like Ms. Medic Aid, U.K.
2002-Brawn Pharmaceuticals Ltd has informed that the Board of Directors at its meeting held on December 10, 2002 has accepted the resignation of Shri Satinder Kumar Saini as Director of the Company.
-Brawn Pharmaceuticals Ltd has appointment of Shri. Manohar Lal, Shri. Mahesh Kumar Nanchal and Shri. Trilok Chand Sharma as Additional Directors of the Company w.e.f. January 10, 2007.